Bardaji A - Search Results

1

Biomarkers and short-term prognosis in COVID-19.

Peiró ÓM, Carrasquer A, Sánchez-Gimenez R, Lal-Trehan N, Del-Moral-Ronda V, Bonet G, Fort-Gallifa I, Picó-Plana E, Bastón-Paz N, Gutiérrez C, Bardaji A. Peiró ÓM, et al. Among authors: bardaji a. Biomarkers. 2021 Mar;26(2):119-126. doi: 10.1080/1354750X.2021.1874052. Epub 2021 Jan 18. Biomarkers. 2021. PMID: 33426934 Free PMC article.

2

Microalbuminuria in normotensive patients with autosomal-dominant polycystic kidney disease.

Martinez-Vea A, Gutierrez C, Bardají A, Pastor R, García C, Peralta C, Richart C, Oliver JA. Martinez-Vea A, et al. Among authors: bardaji a. Scand J Urol Nephrol. 1998 Sep;32(5):356-9. doi: 10.1080/003655998750015331. Scand J Urol Nephrol. 1998. PMID: 9825400

3

Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease.

Bardají A, Vea AM, Gutierrez C, Ridao C, Richart C, Oliver JA. Bardají A, et al. Am J Kidney Dis. 1998 Dec;32(6):970-5. doi: 10.1016/s0272-6386(98)70071-x. Am J Kidney Dis. 1998. PMID: 9856512

4

Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease.

Valero FA, Martinez-Vea A, Bardají A, Gutierrez C, Garcia C, Richart C, Oliver JA. Valero FA, et al. Among authors: bardaji a. J Am Soc Nephrol. 1999 May;10(5):1020-6. doi: 10.1681/ASN.V1051020. J Am Soc Nephrol. 1999. PMID: 10232688

5

Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors.

Martinez-Vea A, Valero FA, Bardaji A, Gutierrez C, Broch M, Garcia C, Richart C, Oliver JA. Martinez-Vea A, et al. Among authors: bardaji a. Am J Nephrol. 2000 May-Jun;20(3):193-200. doi: 10.1159/000013583. Am J Nephrol. 2000. PMID: 10878400

6

Cardiac involvement in autosomal-dominant polycystic kidney disease: a hypertensive heart disease.

Bardají A, Martinez-Vea A, Valero A, Gutierrez C, Garcia C, Ridao C, Oliver JA, Richart C. Bardají A, et al. Clin Nephrol. 2001 Sep;56(3):211-20. Clin Nephrol. 2001. PMID: 11597036

7

A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients.

Vendrell J, Fernandez-Real JM, Gutierrez C, Zamora A, Simon I, Bardaji A, Ricart W, Richart C. Vendrell J, et al. Among authors: bardaji a. Atherosclerosis. 2003 Apr;167(2):257-64. doi: 10.1016/s0021-9150(02)00429-x. Atherosclerosis. 2003. PMID: 12818408

8

Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD.

Martinez-Vea A, Salvadó E, Bardají A, Gutierrez C, Ramos A, García C, Compte T, Peralta C, Broch M, Pastor R, Angelet P, Marcas L, Saurí A, Oliver JA. Martinez-Vea A, et al. Among authors: bardaji a. Am J Kidney Dis. 2006 Feb;47(2):241-50. doi: 10.1053/j.ajkd.2005.10.029. Am J Kidney Dis. 2006. PMID: 16431253

9

Cystatin C and cardiac hypertrophy in primary hypertension.

Prats M, Font R, Bardají A, Gutierrez C, Lalana M, Vilanova A, Martinez-Vea A. Prats M, et al. Among authors: bardaji a. Blood Press. 2010 Feb;19(1):20-5. doi: 10.3109/08037050903416386. Blood Press. 2010. PMID: 20113216

10

Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease.

Martinez-Vea A, Marcas L, Bardají A, Romeu M, Gutierrez C, García C, Compte T, Nogues R, Peralta C, Giralt M. Martinez-Vea A, et al. Among authors: bardaji a. Clin Nephrol. 2012 Mar;77(3):171-81. doi: 10.5414/cn107309. Clin Nephrol. 2012. PMID: 22377247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

318 results

Search Page